ヨーロッパの糖尿病市場は2020年から2024年にかけて力強い成長を遂げ、年平均成長率（CAGR）10.3%を達成しました。この上昇傾向は今後も続くと予想され、2025年から2029年にかけては年平均成長率（CAGR）8.0%で成長すると予測されています。2029年末までに、糖尿病市場は2024年の217億1,620万米ドルから約352億7,230万米ドルに拡大すると予測されています。
ヨーロッパの糖尿病装置および治療薬市場は、糖尿病罹患率の上昇、デジタルヘルスの統合拡大、そして規制枠組みの見直しにより進化を遂げています。これらのトレンドは今後2〜4年でさらに加速し、ヨーロッパ全域において、よりデータに基づいた、政策に沿った糖尿病管理アプローチが進むと予想されます。
ヨーロッパの糖尿病装置および治療薬市場は、老舗企業と地域ニーズに適応する新興の現地企業が混在する特徴があります。戦略的提携と市場統合の傾向に伴い、今後2〜4年は、地域密着型の開発と規制の整合性を重視した競争環境の再編が進むと予想されます。
市場には、既存の多国籍企業に加え、ヨーロッパの規制環境に注力する現地メーカーも存在します。最近の発表によると、多様な製品ポートフォリオを持つ多様な市場構造が、地域の臨床ニーズとコストニーズに対応しています。
本レポートは、ヨーロッパの糖尿病業界における詳細なデータ中心の分析を提供し、診断・モニタリング機器、治療薬、領域など、幅広い分野にわたる市場機会と分析を網羅しています。国レベルで50以上のKPIを網羅した本レポートは、糖尿病市場のダイナミクス、市場規模と予測、そして市場シェア統計に関する包括的な理解を提供します。
BioIntel360の調査手法は、業界のベストプラクティスに基づいています。独自の分析プラットフォームを活用した公平な分析により、新興ビジネスおよび投資市場の機会に関する詳細な見解を提供します。
1. ヨーロッパの糖尿病装置および治療薬市場機会と将来成長ダイナミクス（データブック）
2. オーストリアの糖尿病装置および治療薬市場機会と将来成長ダイナミクス（データブック）
3. ベルギーの糖尿病装置および治療薬市場機会と将来成長ダイナミクス（データブック）
4. デンマークの糖尿病装置および治療薬市場機会と将来成長ダイナミクス（データブック）
5. フランスの糖尿病装置および治療薬市場機会と将来成長ダイナミクス（データブック）
6. ドイツの糖尿病装置および治療薬市場機会と将来成長ダイナミクス（データブック）
7. アイルランドの糖尿病装置および治療薬市場機会と将来成長ダイナミクス（データブック）
8. イタリアの糖尿病装置および治療薬市場の機会と将来の成長ダイナミクス（データブック）
9. オランダの糖尿病装置および治療薬市場の機会と将来の成長ダイナミクス（データブック）
10. ポーランドの糖尿病装置および治療薬市場の機会と将来の成長ダイナミクス（データブック）
11. ロシアの糖尿病装置および治療薬市場の機会と将来の成長ダイナミクス（データブック）
12. スペインの糖尿病装置および治療薬市場の機会と将来の成長ダイナミクス（データブック）
13. スイスの糖尿病装置および治療薬市場の機会と将来の成長ダイナミクス（データブック）
14. イギリスの糖尿病装置および治療薬市場の機会と将来の成長ダイナミクス（データブック）
本レポートは、2020年から2029年までのヨーロッパの糖尿病装置および治療薬市場について、データに基づいた詳細な分析を提供しています。主要な市場セグメントの概要は以下のとおりです。
目次
Table of Contents
This title from BioIntel360 is a bundled offering, combining the following 14 regional and country reports covering 560 tables and 756 figures:
Regional Report - Europe Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 1 - Austria Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 2 - Belgium Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 3 - Denmark Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 4 - France Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 5 - Germany Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 6 - Ireland Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 7 - Italy Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 8 - Netherlands Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 9 - Poland Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 10 - Russia Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 11 - Spain Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 12 - Switzerland Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 13 - United Kingdom Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
All global, regional, and country reports mentioned above will have the following tables of contents:
1 About this Report
1.1 Research Methodology
1.2 Disclaimer
2 Diabetes Devices and Therapeutics Market Size and Forecast, 2020-2029
3 Diabetes Devices and Therapeutics Market Share by Category, 2020-2029
3.1 Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, 2020-2029
3.2 Diabetes Devices and Therapeutics Market Size by Therapeutics, 2020-2029
4 Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2020-2029
4.1 Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, 2020-2029
4.2 Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, 2020-2029
4.3 Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, 2020-2029
4.4 Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, 2020-2029
5 Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2020-2029
5.1 Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, 2020-2029
5.2 Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, 2020-2029
5.3 Diabetes Devices and Therapeutics Market Size by Test Strips, 2020-2029
5.4 Diabetes Devices and Therapeutics Market Size by Lancets, 2020-2029
6 Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2020-2029
6.1 Diabetes Devices and Therapeutics Market Size by Insulin Pumps, 2020-2029
6.2 Diabetes Devices and Therapeutics Market Size by Insulin Pens, 2020-2029
6.3 Diabetes Devices and Therapeutics Market Size by Insulin Syringes, 2020-2029
7 Diabetes Devices and Therapeutics Market Share by Therapeutics, 2020-2029
7.1 Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, 2020-2029
7.2 Diabetes Devices and Therapeutics Market Size by Insulin, 2020-2029
7.3 Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, 2020-2029
7.4 Diabetes Devices and Therapeutics Market Size by Combination Drugs, 2020-2029
8 Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2020-2029
8.1 Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors, 2020-2029
8.2 Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors, 2020-2029
8.3 Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors, 2020-2029
9 Diabetes Devices and Therapeutics Market Share by Insulin, 2020-2029
9.1 Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, 2020-2029
9.2 Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, 2020-2029
9.3 Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, 2020-2029
9.4 Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, 2020-2029
10 Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2020-2029
10.1 Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, 2020-2029
10.2 Diabetes Devices and Therapeutics Market Size by Amylin Analogue, 2020-2029
11 Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2020-2029
11.1 Diabetes Devices and Therapeutics Market Size by Combination Insulin, 2020-2029
11.2 Diabetes Devices and Therapeutics Market Size by Oral Combination, 2020-2029
12 Diabetes Devices and Therapeutics Market Share by Route of Administration, 2020-2029
12.1 Diabetes Devices and Therapeutics Market Size by Subcutaneous, 2020-2029
12.2 Diabetes Devices and Therapeutics Market Size by Intravenous, 2020-2029
12.3 Diabetes Devices and Therapeutics Market Size by Others, 2020-2029
13 Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2020-2029
13.1 Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, 2020-2029
13.2 Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, 2020-2029
14 Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2020-2029
14.1 Diabetes Devices and Therapeutics Market Size by Online Pharmacies, 2020-2029
14.2 Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, 2020-2029
14.3 Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, 2020-2029
15 Diabetes Devices and Therapeutics Market Share by End User, 2020-2029
15.1 Diabetes Devices and Therapeutics Market Size by Hospitals, 2020-2029
15.2 Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, 2020-2029
15.3 Diabetes Devices and Therapeutics Market Size by Homecare, 2020-2029
16 Further Reading
16.1 About BioIntel360
16.2 Related Research
16.3 Consulting
List of Tables
This bundled offering has 40 tables across 14 regional and country reports. All regional and country reports will have the following tables:
Table 1: Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Table 2: Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Table 3: Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Table 4: Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 5: Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Table 6: Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Table 7: Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Table 8: Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Table 9: Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 10: Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Table 11: Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Table 12: Diabetes Devices and Therapeutics Market Size by Insulin Pumps, by Value (US$ Million) 2020-2029
Table 13: Diabetes Devices and Therapeutics Market Size by Insulin Pens, by Value (US$ Million) 2020-2029
Table 14: Diabetes Devices and Therapeutics Market Size by Insulin Syringes, by Value (US$ Million) 2020-2029
Table 15: Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Table 16: Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Table 17: Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Table 18: Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Table 19: Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Table 20: Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Table 21: Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Table 22: Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Table 23: Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Table 24: Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Table 25: Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Table 26: Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Table 27: Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Table 28: Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Table 29: Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Table 30: Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Table 31: Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Table 32: Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Table 33: Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Table 34: Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Table 35: Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Table 36: Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Table 37: Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Table 38: Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Table 39: Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Table 40: Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
List of Figures
This bundled offering has 53 figures across 14 regional and country reports. All regional and country reports will have the following figures:
Figure 1: Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Figure 2: Diabetes Devices and Therapeutics Market Share by Category (%), 2020-2029
Figure 3: Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Figure 4: Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Figure 5: Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices (%), 2020-2029
Figure 6: Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 7: Diabetes Devices and Therapeutics Market Size, by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Figure 8: Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Figure 9: Diabetes Devices and Therapeutics Market Size, by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Figure 10: Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices (%), 2020-2029
Figure 11: Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Figure 12: Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 13: Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Figure 14: Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Figure 15: Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices (%), 2020-2029
Figure 16: Diabetes Devices and Therapeutics Market Share by Insulin Pumps, by Value (US$ Million) 2020-2029
Figure 17: Diabetes Devices and Therapeutics Market Share by Insulin Pens, by Value (US$ Million) 2020-2029
Figure 18: Diabetes Devices and Therapeutics Market Share by Insulin Syringes, by Value (US$ Million) 2020-2029
Figure 19: Diabetes Devices and Therapeutics Market Share by Therapeutics (%), 2020-2029
Figure 20: Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Figure 21: Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Figure 22: Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Figure 23: Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Figure 24: Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs (%), 2020-2029
Figure 25: Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Figure 26: Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Figure 27: Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Figure 28: Diabetes Devices and Therapeutics Market Share by Insulin (%), 2020-2029
Figure 29: Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Figure 30: Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Figure 31: Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Figure 32: Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Figure 33: Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs (%), 2020-2029
Figure 34: Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Figure 35: Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Figure 36: Diabetes Devices and Therapeutics Market Share by Combination Drugs (%), 2020-2029
Figure 37: Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Figure 38: Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Figure 39: Diabetes Devices and Therapeutics Market Share by Route of Administration (%), 2020-2029
Figure 40: Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Figure 41: Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Figure 42: Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Figure 43: Diabetes Devices and Therapeutics Market Share by Type of Diabetes (%), 2020-2029
Figure 44: Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Figure 45: Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Figure 46: Diabetes Devices and Therapeutics Market Share by Distribution Channels (%), 2020-2029
Figure 47: Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Figure 48: Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Figure 49: Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Figure 50: Diabetes Devices and Therapeutics Market Share by End User (%), 2020-2029
Figure 51: Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Figure 52: Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Figure 53: Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
